Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?

Wall Street analysts are quite bullish about Intellia Therapeutics (NTLA -2.56%) stock. On average, they're estimating that it'll rise by around 157% within the next 12 months. In the context of the new bull market shaping up right now, it likely has a good shot of actually delivering what analysts are hoping to see. Does that mean this stock's ascent is inevitable in the near term? Or is Wall Street getting ahead of itself?Catalysts are indeed in storeLet's start by examining the case in favor of Intellia ...